Bioventus (BVS) Non-Current Deferred Tax Liability (2020 - 2026)

Bioventus' Non-Current Deferred Tax Liability history runs 7 years deep, the most recent figure standing at $568000.0 for Q1 2026.

• Quarterly Non-Current Deferred Tax Liability fell 6.43% year-over-year to $568000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $568000.0 (down 6.43% YoY) and the FY2025 annual result came in at $433000.0, down 23.23% from the prior year.
• Non-Current Deferred Tax Liability was $568000.0 for Q1 2026 at Bioventus, up from $433000.0 in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $159.3 million in Q4 2022 and bottomed at $351000.0 in Q2 2023.
• A 5-year average of $29.5 million and a median of $786000.0 in 2025 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability slumped 99.7% — and 2024, when it jumped 268.66%.
• Bioventus' Non-Current Deferred Tax Liability stood at $2.2 million in 2022, then slipped by 8.67% to $2.1 million in 2023, then slumped by 72.53% to $564000.0 in 2024, then declined by 23.23% to $433000.0 in 2025, then soared by 31.18% to $568000.0 in 2026.
• Business Quant data shows BVS's Non-Current Deferred Tax Liability at $568000.0 in Q1 2026, $433000.0 in Q4 2025, and $786000.0 in Q3 2025.